Immunocore Holdings plc (IMCR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:33PM EDT. Market open.
| Previous close | 60.23 |
| Open | 60.25 |
| Bid | 61.49 x 100 |
| Ask | 61.82 x 100 |
| Day's range | 59.70 - 61.87 |
| 52-week range | 42.21 - 76.98 |
| Volume | |
| Avg. volume | 414,523 |
| Market cap | 3.083B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Immunocore Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Immunocore Holdings ( NASDAQ:IMCR ) Full Year 2023 Results Key Financial Results Revenue: US$249.4m (up 44% from FY...
- Insider Monkey
Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript
Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript February 28, 2024 Immunocore Holdings plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the Immunocore Fourth Quarter Financial Results Conference Call. At this time, all participants are […]
- GuruFocus.com
Immunocore Holdings PLC (IMCR) Reports Strong Revenue Growth Amidst Expansion and Clinical ...
Full Year and Q4 2023 Earnings Summary: KIMMTRAK Drives Revenue Surge as Clinical Pipeline Progresses
© 2024 Yahoo. All rights reserved.